European Archives - Page 345 of 1138 - European Medical Journal

Global Implementation of Respiratory Syncytial Virus Interventions

The 8th Respiratory Syncytial Virus Foundation (ReSViNET) Conference took place in Mumbai, India, between…

Spotlight: February 2024

GOLD looks back on some of the top pharma news stories from the past month, including new approvals, the latest appointments and departures in the industry and more.

Blood Biomarker Test Improves Diabetes Prediction

A new study focused on the connection between systematic inflammation and Type 2 diabetes. Joint assessment of biomarkers, has been shown to improve the risk prediction of T2D.

Bariatric Surgery Superior Option for Long-Term Blood Glucose Control

Patients with Type 2 diabetes who underwent bariatric surgery have demonstrated favourable long-term diabetes control, when compared those receiving medical management and lifestyle interventions.

Extreme Heat Linked to Preterm Birth

New research from Monash University in Melbourne, Australia, has identified a relationship between extreme heat exposure and preterm birth risk.

Is Polycystic Ovary Syndrome Linked to Cardiovascular Disease?

According to studies, polycystic ovary syndrome is a prevalent and genetically complex disorder that poses a heightened risk of cardiovascular disease and affects 5–15% of reproductive-age females.

Can High-Dose Vitamin D Supplements Reduce Repeat Pneumonia Episodes in Children?

A systematic review regarding the benefits of using high-dose vitamin D supplements in paediatric populations was presented at the 8th Respiratory Syncytial Virus Foundation (ReSViNET) Conference. Researchers found that the use of vitamin D does not reduce rates of mortality in paediatric patients with pneumonia.

EMJ Hematology 12 [Supplement 1] 2024

Welcome to our supplement providing an excellent review of the European Association for Haemophilia and Allied Disorders (EAHAD)…

Follow-Up Care Models Post-Cancer Treatment

After being diagnosed with cancer, patients embark on a journey that involves ongoing treatments, and regular visits to healthcare…

Identifying Preterm Infants at Risk of Respiratory Syncytial Virus Hospitalisation

Research presented at the 8th Respiratory Syncytial Virus Network (ResViNET) Conference identified a risk scoring tool (RST) for classifying moderate-to-late preterm infants at greatest risk of respiratory syncytial virus (RSV) hospitalisation.